Ourofino SA OFSA3
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- BRL 20.49
- Day Range
- BRL 20.01–20.32
- 52-Week Range
- BRL 18.20–26.01
- Bid/Ask
- BRL 0.00 / BRL 0.00
- Market Cap
- BRL 1.09 Bil
- Volume/Avg
- 3,400 / 4,525
Key Statistics
- Price/Earnings (Normalized)
- 15.67
- Price/Sales
- 1.17
- Dividend Yield (Trailing)
- 1.64%
- Dividend Yield (Forward)
- 1.64%
- Total Yield
- 1.64%
Company Profile
Ourofino SA is engaged in the production and sale of veterinary drugs, vaccines, and other products for cattle, pigs, poultry, sheep, horses goats, and pets. The company's reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimastitics, Biological, Ectoparasiticides, Endectocides, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,201
Comparables
Valuation
|
Metric
|
OFSA3
|
600201
|
300967
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.67 | 26.15 | — |
Price/Book Value | 1.62 | 1.52 | 3.08 |
Price/Sales | 1.17 | 5.30 | 2.83 |
Price/Cash Flow | 12.23 | 15.52 | 127.01 |
Price/Earnings
OFSA3
600201
300967
Financial Strength
|
Metric
|
OFSA3
|
600201
|
300967
|
|---|---|---|---|
Quick Ratio | 2.13 | 2.72 | 0.35 |
Current Ratio | 3.08 | 3.20 | 0.73 |
Interest Coverage | 3.87 | 53.65 | −2.85 |
Quick Ratio
OFSA3
600201
300967
Profitability
|
Metric
|
OFSA3
|
600201
|
300967
|
|---|---|---|---|
Return on Assets (Normalized) | 5.45% | 3.52% | −10.04% |
Return on Equity (Normalized) | 10.41% | 4.51% | −21.49% |
Return on Invested Capital (Normalized) | 8.39% | 3.47% | −8.61% |
Return on Assets
OFSA3
600201
300967
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Lwnztztpw | Grcvf | $86.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Mmxzrqjkdr | Fmqwb | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Vvcbjsj | Xrfj | $46.6 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Wxtwtvn | Xrs | $19.9 Bil | |||
| Viatris Inc
VTRS
| Sjlmgfwn | Cfww | $13.6 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Yhdppqwl | Lldq | $13.4 Bil | |||
| Catalent Inc
CTLT
| Kyyjhnwr | Djphvm | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Gpyjpnv | Vftxw | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Shlcqfz | Blj | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Wlkrsrpn | Myjb | $2.5 Bil |
United States